Feasibility of a combination of high dose chemotherapy ifosfamide, carboplatin, etoposide (ICE) plus stem cells and bevacizumab in refractory sarcoma and germ cell tumors.

被引：0
|
作者：
Jordan, K [1 ]
Kegel, T [1 ]
Mueller, LP [1 ]
Kinitz, I [1 ]
Schmoll, HJ [1 ]
机构：
[1] Univ Halle Wittenberg, Halle Saale, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：833S / 833S
页数：1
相关论文
共 50 条
  • [1] P-ICE: sequential high-dose-chemotherapy with Paclitaxel, Ifosfamide, Carboplatin, Etoposide in refractory germ cell tumors
    Cygon, F.
    Meinert, F.
    Hammad, K.
    Steinbach, F.
    Seseke, F.
    Schmoll, H. -J.
    Kegel, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 95 - 95
  • [2] Paclitaxel plus ifosfamide followed by high-dose carboplatin plus etoposide in previously treated germ cell tumors
    Kondagunta, G. Varuni
    Bacik, Jennifer
    Sheinfeld, Joel
    Bajorin, Dean
    Bains, Manjit
    Reich, Lillian
    Deluca, John
    Budnick, Amy
    Ishill, Nicole
    Mazumdar, Madhu
    Bosl, George J.
    Motzer, Robert J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (01) : 85 - 90
  • [3] Bevacizumab plus high-dose ifosfamide, etoposide and carboplatin (HD-ICE) as third-line salvage chemotherapy induced an unexpected dramatic response in highly platinum refractory germ-cell cancer
    Voigt, W
    Kegel, T
    Maher, G
    Jordan, K
    Müller, L
    Schmoll, HJ
    ANNALS OF ONCOLOGY, 2006, 17 (03) : 531 - U6
  • [4] Phase II-study of sequential High-Dose-Chemotherapy with Paclitaxel, Ifosfamide, Carboplatin, Etoposide (P-ICE) in patients with relapsed or refractory germ cell tumors (GCT)
    Cygon, F.
    Meinert, F.
    Hammad, K.
    Kegel, T.
    Steinbach, F.
    Seseke, F.
    Schmoll, H. -J.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 10 - 11
  • [5] Phase II-study of sequential high-dose-chemotherapy with paclitaxel, ifosfamide, carboplatin, etoposide(P-ICE) in patients with relapsed or refractory germ cell tumors (GCT).
    Kegel, Thomas
    Cygon, Franziska
    Meinert, Fabian Maximilian
    Hannmad, Khaled
    Steinbach, Frank
    Seseke, Florian
    Schmoll, Hans-Joachim
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [6] SALVAGE CHEMOTHERAPY IN REFRACTORY GERM-CELL TUMORS WITH ETOPOSIDE (VP-16) PLUS IFOSFAMIDE PLUS HIGH-DOSE CISPLATIN - A VIHP REGIMEN
    GHOSN, M
    DROZ, JP
    THEODORE, C
    PICO, JL
    BAUME, D
    SPIELMANN, M
    OSTRONOFF, M
    MORAN, A
    SALLOUM, E
    KRAMAR, A
    HAYAT, M
    CANCER, 1988, 62 (01) : 24 - 27
  • [7] HIGH-DOSE CARBOPLATIN AND ETOPOSIDE FOR SALVAGE CHEMOTHERAPY OF GERM-CELL TUMORS
    LAMPE, H
    DEARNALEY, DP
    PRICE, A
    MEHTA, J
    POWLES, R
    NICHOLLS, J
    HORWICH, A
    EUROPEAN JOURNAL OF CANCER, 1995, 31A (05) : 717 - 723
  • [8] Salvage chemotherapy with high dose carboplatin plus etoposide (HDCE) and peripheral blood stem cell transplant (PBSCT) in patients with germ cell tumors (GCT).
    Einhorn, L. H.
    Williams, S.
    Abonour, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 228S - 228S
  • [9] HIGH-DOSE CARBOPLATIN, ETOPOSIDE AND IFOSFAMIDE FOLLOWED BY AUTOLOGOUS STEM-CELL TRANSPLANTATION IN POOR RISK GERM-CELL TUMORS
    SIEGERT, W
    BEYER, J
    STROHSCHEER, I
    WEISBACH, V
    HEUFT, HG
    OETTLE, H
    ZINGSEM, J
    ECKSTEIN, R
    SCHMOLL, HJ
    HUHN, D
    BONE MARROW TRANSPLANTATION, 1992, 10 : 26 - 26
  • [10] Paclitaxel Plus Ifosfamide Followed by High-Dose Carboplatin Plus Etoposide for Patients With Relapsed Primary Mediastinal Nonseminomatous Germ Cell Tumors: Benefit From Chemotherapy, Surgery, or Both?
    Einhorn, Lawrence H.
    Abonour, Rafat
    Kesler, Kenneth A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (35) : E739 - E739
12345